Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Jurnal Administrasi Kesehatan Indonesia
Ahmat, Azmi Nor Mohd Farez
Unknown Affiliation
Health Professions

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
ASSESSING THE DISTRIBUTION OF SELF-PAYING INNOVATIVE ONCOLOGY MEDICINES AMONG CANCER PATIENTS Dzulkipli, Mohd Redhuan; Shafie, Asrul Akmal; Maon, Siti Noorsuriani; Ramli, Azuana; Mohammad Yahaya, Abdul Haniff; Ho, See Wan; Muhsin, Nor Ilham Ainaa; Ahmat, Azmi Nor Mohd Farez
Indonesian Journal of Health Administration (Jurnal Administrasi Kesehatan Indonesia) Vol. 13 No. 2 (2025): December
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jaki.v13i2.2025.162-171

Abstract

Background: Innovative oncology medicines offer advanced cancer treatment but often come with high costs, limiting access through public healthcare funding. Aims: This study examines the distribution of self-paying innovative cancer drugs among patients in Malaysian public hospitals. Methods: Using oncology pharmacy records from 2017 to 2020, 157 patient samples were collected, constrained by COVID-19 restrictions. Results: The average patient age was 57 years (SD= 11.47), with a predominance of females (73.9%) and Chinese ethnicity (48%). Breast cancer was the most common diagnosis (47%), followed by lung (17%) and colon cancer (10%). Frequently prescribed drugs included Trastuzumab, Palbociclib, Osimertinib, Cetuximab, and Bevacizumab, most of which are listed in the Ministry of Health’s Formulary of Listed Anticancer Drugs (FLAD). Patients paid an average annual cost of MYR 16,233.90 (SD= 20,424.67) for FLAD medicines and MYR 11,239.75 (SD= 122,793.50) for non-FLAD medicines. Conclusion: The study highlights that out-of-pocket payments are the primary funding source for these treatments, posing significant financial burdens and potential long-term economic strain on cancer patients in Malaysia. Keywords: FLAD, Funding Mechanism, Innovative Oncology Medicine
Co-Authors Dzulkipli, Mohd Redhuan Ho, See Wan Maon, Siti Noorsuriani Mohammad Yahaya, Abdul Haniff Muhsin, Nor Ilham Ainaa Ramli, Azuana Shafie, Asrul Akmal